These medicines are commonly given together for people who have both diabetes and high blood pressure. Telmisartan, Gliclazide, Metformin, and Cilnidipine can usually be taken on the same day if your doctor has prescribed them that way. In many cases, some of these medicines are taken together after food to reduce stomach discomfort and help maintain stable sugar levels. Still, the timing may differ depending on your blood pressure readings, sugar control, kidney function, and overall health condition. Taking them incorrectly or skipping meals can sometimes lead to dizziness, weakness, sweating, or sudden drops in blood sugar. That is why following the schedule advised by your doctor is important. Try to take your medicines at the same time every day, avoid missing meals, drink enough water, and monitor your blood sugar and blood pressure regularly. Avoid changing doses or combining extra medicines without medical guidance. Consult your doctor if you develop severe dizziness, swelling, fainting, very low sugar readings, or unusual weakness after taking the medicines.

Your blood sugar readings are staying quite high, which means your diabetes may not be fully controlled right now. Metformin, Pioglitazone, Glimepiride, Glipizide, and Gliclazide can help many people, but sometimes sugar levels remain high because of an irregular diet, stress, poor sleep, low physical activity, weight gain, or the body becoming less responsive to treatment over time. A detailed medical review is important because your doctor may need to check HbA1c, kidney function, diet pattern, and whether the current treatment plan is suitable for you. In some cases, dose adjustments or different treatment combinations may be required after proper evaluation. Try to reduce sweets, sugary drinks, white rice, bakery foods, and late-night eating. Eating smaller, balanced meals, walking regularly after food, maintaining proper sleep, and checking sugar levels consistently may help improve control gradually. Consult your doctor if you develop excessive thirst, frequent urination, blurred vision, weight loss, severe weakness, or persistently high readings despite treatment.